Disease relevance of Pancreatic Pseudocyst

• The concentrations of cefepime in pancreatic pseudocyst fluid (n = 4), pancreatic tissue (n = 4) and pancreatic fistula fluid (n = 1), and simultaneous plasma concentrations, were measured after intravenous administration of a single 2 g dose to nine patients [1].
• Somatostatin in the treatment of pancreatic pseudocyst complicating acute pancreatitis in a child with liver transplantation [2].
• A case of successful conservative surgical and obstetric management of chronic pancreatitis and pancreatic pseudocyst in a pregnant Pima Indian is presented [3].
• Somatostatin analogue in treatment of coexisting glucagonoma and pancreatic pseudocyst: dissociation of responses [4].
• The use of Sandostatin in acute esophageal variceal bleeding, pancreatic pseudocysts, gastrointestinal, and pancreatic external fistulae, short bowel syndrome, dumping syndrome and acquired immunodeficiency syndrome (AIDS)-related refractory hypersecretory diarrhea has provided encouraging results.(ABSTRACT TRUNCATED AT 250 WORDS)[5]

Psychiatry related information on Pancreatic Pseudocyst

• Based on these findings, the final diagnosis was parotid enlargement and acute exacerbation of chronic pancreatitis associated with a pancreatic pseudocyst in a patient with an eating disorder [6].

High impact information on Pancreatic Pseudocyst

• Treatment of pancreatic pseudocysts with octreotide [7].
• This and previously reported cases of new-onset diabetes following this procedure suggest close serum glucose monitoring in all patients undergoing percutaneous pancreatic pseudocyst drainage [8].
• Successful treatment of pancreatic pseudocyst with a somatostatin analogue and catheter drainage [9].
• Pancreatic pseudocysts (Part I) [10].
• We conclude that uncomplicated pancreatic pseudocysts in patients with primary hyperparathyroidism can be treated expectantly [11].

Chemical compound and disease context of Pancreatic Pseudocyst

• In each patient, the preoperative elevations of serum alkaline phosphatase and serum bilirubin levels returned to normal limits after operative decompression of a pancreatic pseudocyst alone without an accompanying or subsequent bilioenteric bypass being required [12].
• The limited role of total parenteral nutrition in the management of pancreatic pseudocyst [13].
• BACKGROUND AND STUDY AIMS: Portal hypertension often coexists with pancreatic pseudocysts and is potentially dangerous if a collateral vessel is in the vicinity of the needle puncture pathway [14].
• This paper reports on a patient who was treated by percutaneous aspiration, instillation of a sclerosant (polidocanol) and cystogastric drainage for a post-acute pancreatic pseudocyst [15].
• Pancreatic pseudocyst caused by valproic acid: case report and review of the literature [16].

Biological context of Pancreatic Pseudocyst

• We report a patient with Pi-SS phenotype alpha 1-antitrypsin deficiency and chronic pancreatitis complicated by recurrent pancreatic pseudocysts and chronic abdominal pain [17].

Anatomical context of Pancreatic Pseudocyst

• The aim of this study was to test the GI hormonal changes and gallbladder motility during CJF in patients with pancreatic pseudocysts following acute pancreatitis, with or without octreotide pretreatment [18].
• METHODS AND RESULTS: We report five cases of VHL with a polycystic pancreas as the main or only manifestation, all devoid of symptoms related to involvement of the pancreas, who were referred to our Pancreatic Surgery center with diagnoses of multiple pancreatic pseudocysts of undefined origin [19].
• Increased viscosity and raised lactoferrin, trypsin and protein concentrations in selectively aspirated pancreatic secretion, prompted us to try depot secretin therapy in patients with advanced chronic recurrent pancreatitis without pancreatic duct obstruction or pancreatic pseudocysts [20].

Gene context of Pancreatic Pseudocyst

• Also, therapeutic EUS procedures, such as EUS-guided celiac plexus neurolysis, pancreatic tumor ablation, drainage of pancreatic pseudocysts, and the development of an anastomosis may become feasible as less invasive and safer techniques than those used at present [21].
• Patients developing an acute pancreatic pseudocyst had high levels of activated trypsin in complex with alpha 1-protease inhibitor, together with a probable activation of the kinin, complement, coagulation and fibrinolytic systems [22].
• Pancreatic pseudocyst in paediatric systemic lupus erythematosus [23].
• Two weeks after laparatomy U/S and CT showed a dilated CBD and two Pancreatic Pseudocysts [24].
• Pancreatic pseudocyst observed on F-18 FDG PET imaging [25].

Analytical, diagnostic and therapeutic context of Pancreatic Pseudocyst

• Also in human pancreatic pseudocysts, high and persistent concentrations of cefotaxime were found following intravenous injection [26].

References